Most Popular
-
1
Tensions heighten ahead of first president-opposition chief meeting
-
2
Seoul to provide housing subsidy to married couples with newborns
-
3
[KH Explains] No more 'Michael' at Kakao Games
-
4
Rapper jailed after public street fight with another rapper
-
5
Woman gets suspended term for injuring boyfriend with knife
-
6
Samsung chief bolsters ties with Germany’s Zeiss
-
7
NewJeans pops out ‘Bubble Gum’ video amid troubles at agency
-
8
Med schools expect 1,500+ new admission slots next year
-
9
Nominee for chief of anti-corruption body pledges 'independence, effectiveness'
-
10
KT launches new mobile plans for foreign residents
-
Sungrow Powers World's Largest BIPV Project
With a capacity of 120 MW and installed with Sungrow inverter solutions GAOAN, China, Aug. 24, 2022 /PRNewswire/ -- Sungrow, the global leading inverter and energy storage solution supplier, announced that the Company supplies its featured inverter solutions to a 120 MW BIPV (Building Integrated Photovoltaic) plant in Gaoan, Central China's Jiangxi Province. The project is the world's largest BIPV project to date and was commissioned for the first phase in June 2022. 120MW BIPV Project
Aug. 24, 2022
-
"NOWCITY" Music Festival & Lifestyle Fair ignites the summer night in Changsha, China
CHANGSHA, China, Aug. 24, 2022 /PRNewswire/ -- Leading online travel service provider Trip.com Group hosted Traveler's Night, and "NOWCITY" Music Festival & Lifestyle Fair from August 18 to August 20 in Changsha, the capital of Hunan province in central China. Gathering over 20,000 Ctrip Community users, influencers, and avid travelers, the event offered Internet nomads an opportunity to reconnect offline, exchange travel insights and spark travel inspiration. Trip.com Group an
Aug. 24, 2022
-
CNN's 'Tech for Good' explores the world of nature-inspired technology
HONG KONG, Aug. 24, 2022 /PRNewswire/ -- Millions of years of animal evolution have resulted in the development of many biological features that have helped different species adapt and survive. Increasingly, scientists and researchers are taking note of these intelligent features – and have begun looking to nature to unlock greater potential in our technologies through bio-inspired engineering. On the next episode of 'Tech for Good', CNN anchor and correspondent Kristie Lu Stout explores th
Aug. 24, 2022
-
Innodisk Announces AI Strategy with Leading Partners to Empower Intelligent Operations
TAIPEI, Aug. 24, 2022 /PRNewswire/ -- Innodisk, a global leader in industrial storage and embedded peripherals has officially announced Innodisk Group's new development strategy focusing on the AI market, and also launched the "Innodisk AI" Solution at a press conference in Taipei, Taiwan. Innodisk has amassed more than 1,000 successful cases worldwide since the business expand to AIoT in 2017. In the coming years Innodisk will continue to extend its ecosystem alliance, and expand it
Aug. 24, 2022
-
Mangosteen Peel as Medicine - CU's Faculty of Veterinary Science is Successful in Replicating Mangosteen Peel Extract, Treatment for Intestinal Inflammation in Humans and Animals
BANGKOK, Thailand, Aug. 24, 2022 /PRNewswire/ -- The Faculty of Veterinary Science, Chulalongkorn University has researched and replicated "Hydroxy-xanthones", the vital extracts rich in antioxidants found in mangosteen peels that kill germs and halt infections in the intestinal mucosa. It hopes to expand to include health products for humans and animals in the future. Not only is "Mangosteen", the queen of Thai fruits, a delicious and healthy fruit, but its
Aug. 24, 2022
-
First US Patient Enrolled in SELUTION SLR IDE Peripheral Study
GENEVA, Switzerland, Aug. 24, 2022 /PRNewswire/ -- The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial evaluating SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon. This milestone follows Investigational Device Exemption (IDE) approval in the US in May 2022, with enrollment of the first patient occurring in Germany one week after approval. First US Patient Enrolled in SELUTION SLR IDE Peripheral Study &n
Aug. 24, 2022
-
STARLIGHT KNIGHT LATIYA PIERCES HER WAY THROUGH ENEMIES' HEARTS IN VINDICTUS
Latiya will join as the 21st hero and a special in-game event will occur to celebrate her arrival SEOUL, South Korea, Aug. 24, 2022 /PRNewswire/ -- Knight-errant and magical master of joust Latiya is now available to play in Nexon's MMORPG Vindictus, earning her place as the 21st hero in the game. Latiya grew up in a dangerous jungle and became the world's greatest hunter, yet her desire to become a knight overtook that ambition. With her large lance and mystic chain hook, she hurtles through
Aug. 24, 2022
-
eQ Technologic revolutionizes ease of data integration & analytics with eQube® Cloud
COSTA MESA, Calif., Aug. 23, 2022 /PRNewswire/ -- eQ Technologic, the providers of eQube®-DaaS (Data as a Service) Platform, announced earlier today the launch of a new format in which their products can be accessed: a next-gen cloud-native solution for data / application integration and analytics challenges - the eQube® Cloud. eQube® Cloud Free 15-Day Trial | eQ Technologic (1eQ.com) eQ Technologic revolutionizes ease of data integration & analytics w
Aug. 23, 2022
-
Industry Market Leader Pro Music Rights, Inc. (OTC: NUVG) Announces Q2 2022 Results with $432,579,903 in Assets with Significant Share Value Increase for Shareholders
NAPLES, Fla., Aug. 23, 2022 /PRNewswire/ -- Pro Music Rights, Inc. (OTC: NUVG), one of the world's largest music licensing companies, today announced financial results for its second quarter ended June 30, 2022 with its quarterly report which can be found at EDGAR Assets increased to $432,579,903 for the 2nd Quarter of 2022 from $323,562,671 reported EOY 2021, an increase of $109,017,232 in total assets Q to Q bringing book value to $0.12 per share, bringing immediate
Aug. 23, 2022
-
GWM Holds POER Fan Festival 2022, Sharing Full-scenario Pickup Life with Global Users
BAODING, China, Aug. 23, 2022 /PRNewswire/ -- On August 18, GWM held POER Fan Festival 2022 in Guilin city, Southwest China, to celebrate the brand's third anniversary and demonstrate the charm of full-scenario pickup life to international users. GWM Holds POER Fan Festival 2022, Sharing Full-scenario Pickup Life with Global Users GWM invited many experts, media and users from the fields of off-road, modification and outdoor sports to witness this essential moment with POER's global f
Aug. 23, 2022
-
Ping An Reports Steady YoY Growth of 4.3% in Operating Profit Attributable to Shareholders of the Parent Company in 1H2022
Attaching great importance to shareholder returns, annual cash dividend per share grows by 4.5% year on year HONG KONG and SHANGHAI, Aug. 23, 2022 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEX: 2318; SSE: 601318) today announced its 2022 interim results for the six month period ended 30 June 2022. 2022 is a critical year for Ping An's cultural reshaping, strategic upgrade
Aug. 23, 2022
-
ValueChampion brings HSBC, IG, Allianz & More to Finance Metaverse World
SINGAPORE, Aug. 23, 2022 /PRNewswire/ -- Bringing innovation and knowledge sharing to a new level in the finance space, ValueChampion is launching an immersive Metaverse finance world with HSBC, Allianz Insurance Singapore/Allianz Partners, Advisors Alliance Group (Representing AIA Financial Advisers Pte Ltd), Funding Societies, and IG to bring about a new mode of storytelling. ValueChampion is launching a Web 3.0 Metaverse finance world with HSBC, Allianz Insurance Singapore/Allianz Partn
Aug. 23, 2022
-
'We Have Promises to Keep' - Education Cannot Wait Investments Reach 7 Million Crisis-Impacted Children
NEW YORK, Aug. 23, 2022 /PRNewswire/ -- Education Cannot Wait (ECW), the United Nations global fund for education in emergencies and protracted crises, issued its new "We Have Promises to Keep: Annual Results Report" today indicating that ECW investments with strategic partners have reached close to 7 million children and adolescents – 48.4% of whom are girls – since the Fund became operational in 2017. New ECW Annual Results Report highlights impact of the United Na
Aug. 23, 2022
-
Firmenich Receives SBTi Approval For Net-Zero Emissions Target
Firmenich is the first company in the industry to receive approval from the Science Based Targets initiative (SBTi) for its net-zero emissions target GENEVA, Aug. 23, 2022 /PRNewswire/ -- Firmenich, the world's largest privately-owned fragrance and taste company, has received approval from the Science Based Targets initiative (SBTi) for its net-zero emissions target, making it the first company in the industry and one of the first companies globally to receive approval from the SBTi.
Aug. 23, 2022
-
Sasol posts strong financial results supported by macroeconomic environment
Black-owned businesses spend in South Africa up 40% to R33,6 billion of R55,8 billion B-BBEE spend Invested R1,2 billion in skills development Key terms agreed with IPPs for more than 600MW of renewable energy for SA Operations Balance sheet strengthened with net debt down to US$3,8 billion Reinstatement of dividend of R14,70 per share Earnings before interest and tax (EBIT) up by more than 100% to R61,4 billion Earnings per share up more than 100% to R62,34, core headline earning
Aug. 23, 2022
-
Pylontech Added to MSCI China A Onshore Index
SHANGHAI, Aug. 23, 2022 /PRNewswire/ -- Pylontech (688063), a dedicated battery storage system (BSS) provider listed on the Shanghai Stock Exchange STAR MARKET (SSE), was added to the MSCI China A Onshore Index and MSCI China All Shares Index on August 11, 2022. MSCI, as a leading provider of critical decision support tools and services for the global investment community, announced the changes in its August 2022 Quarterly Index Review for the MSCI Equity Indexes. In this review, MSCI Ch
Aug. 23, 2022
-
GenScript ProBio Congratulates Selecxine on FDA Clearance of IND Application for Innovative Antibody Drug Program
NANJING, China, Aug. 23, 2022 /PRNewswire/ -- Recently, Selecxine, a partner of GenScript ProBio, announces FDA clearance of its IND application for innovative antibody drug program (SLC-3010). GenScript ProBio was responsible for the CMC development and supporting IND filing in this project. GenScript ProBio extends congratulations on this. In December 2019, GenScript ProBio announced the strategic collaboration with Selecxine for an innovative antibody drug program. The project (
Aug. 23, 2022
-
Wemade Holds the 1st Anniversary Event of MIR4 Global Service!
Starting today (23rd), "Divine Dragon's Blessing", hunting and attendance events will be held Expanding communication with users through MIR4 official community events Introducing new servers for only NFT characters to enter to provide a pleasant playing environment SEOUL, South Korea, Aug. 23, 2022 /PRNewswire/ -- Wemade's masterpiece MMORPG MIR4 will hold events to celebrate the 1st anniversary of its global service. Wemade Holds the 1st Ann
Aug. 23, 2022
-
Coins.ph Teams Up with OK Remit to Enable Low-Cost Remittances from Japan to the Philippines via RippleNet
On-Demand Liquidity service on Ripple's payment network provides instant and cost-effective way for the large community of Filipinos in Japan to send money home, empowering overseas workers through financial inclusion MANILA, Philippines, Aug.23, 2022 /PRNewswire/ -- Coins.ph ("Coins" or the "Company"), the Philippines' leading digital wallet provider and crypto exchange platform, and Asian Net Co., Ltd., a money transfer company in Japan operating under the brand name of O
Aug. 23, 2022
-
Announcement of 2022 Future Science Prize Winners: Wenhui Li, Xueming Yang, Ngaiming Mok
BEIJING, Aug. 23, 2022 /PRNewswire/ -- The Future Science Prize committee announces the winners of 2022 on August 21st. Prof. Wenhui Li from National Institute of Biological Sciences, Beijing, China; Tsinghua Institute of Multidisciplinary Biomedical Research receives the Future Science Prize in life sciences for his discovery of the Hepatitis B and D virus receptor, sodium taurocholate cotransporting polypeptide (NTCP). This discovery facilitates the development of more effective treatment
Aug. 23, 2022